Rescue therapy for gastrointestinal (GI) refractory bleeding, perforation, and fistula has traditionally required surgical interventions owing to the limited performance of conventional endoscopic instruments and techniques. An innovative clipping system, the over-the-scope clip (OTSC), may play an important role in rescue therapy. This innovative device is proposed as the final option in endoscopic treatment. The device presents several advantages including having a powerful sewing force for closure of GI defects using a simple mechanism and also having an innovative feature, whereby a large defect and fistula can be sealed using accessory forceps. Consequently, it is able to provide outstanding clinical effects for rescue therapy. This review clarifies the current status and limitations of OTSC according to different indications of GI refractory disease, including refractory bleeding, perforation, fistula, and anastomotic dehiscence. An extensive literature search identified studies reported 10 or more cases in which the OTSC system was applied. A total of 1517 cases described in 30 articles between 2010 and 2018 were retrieved. The clinical success rates and complications were calculated overall and for each indication. The average clinical success rate was 78% (n = 1517) overall, 85% for bleeding (n = 559), 85% (n = 351) for perforation, 52% (n = 388) for fistula, 66% (n = 97) for anastomotic dehiscence, and 95% (n = 122) for other conditions, respectively. The overall and severe OTSC-associated complications were 1.7% (n = 23) and 0.59% (n = 9), respectively. This review concludes that the OTSC system may serve as a safe and productive device for GI refractory diseases, albeit with limited success for fistula.
Introduction
Refractory bleeding, perforation, fistula, and anastomotic dehiscence of the gastrointestinal (GI) tract are conditions resistant to endoscopic treatment and represent the main indications for surgery. There is an unmet need in the development of medical treatments that are less onerous and bridge the gap between endoscopic treatment and surgery. [1] [2] [3] One such proposal was the development of an endoscopic full-thickness suturing device called the overthe-scope clip (OTSC) system (Ovesco Endoscopy GmbH, Tübingen, Germany). Its characteristics, which are not available in conventional equipment, include that it is a simple and rapid system, allowing sustained closure using accessory forceps for large wound surfaces and fistula. Therefore, as a form of relief treatment, the OTSC system can provide remarkable clinical effects. Since Kirschniak et al. 4 reported the clinical utility of the OTSC system for refractory GI disease for the first time in 2007, its use has spread worldwide. [5] [6] [7] Herein, we aimed to clarify the clinical results obtained using the OTSC system for different indications including bleeding, perforation, fistula, and anastomotic dehiscence and to clarify its current status and limitations.
The over-the-scope clip system
The OTSC system is a full-thickness suturing device designed for flexible endoscopes, intended for the closure of the wound surface of target diseases including non-variceal GI bleeding, perforation, fistula, and anastomotic dehiscence. Its main feature is the strong and sustained tissue-grasping force as compared with the conventional hemostatic clips. Furthermore, using dedicated grasping forceps, relatively large defects and perforations can also be sutured. 8 Its suturing capacity is said to be similar to that of surgical staplers. 9 Whereas once the clip is fixed on target lesion, it is difficult to remove and replace the clip. For this reason, the user needs to be familiar with the device in advance through the usage of demonstration.
Mechanism
and application aids of the over-the-scope clip system. The OTSC system consists of an applicator cap, with a mounted clip, a hand wheel, and a thread retriever (Fig. 1) . The mechanism involved is simple. Turning the wheel attached to the working channel of the endoscope, the thread connected to the end cap is pulled, and this deploys the clip to the target (Fig. 2) . This clip, a shape-memory alloy made of Nitinol, allows to complete hemostasis and close perforations through a mechanism that involves the four prongs of the clip to anchor the lesion from the left and right, which allows continuously compressing the tissue. In addition, because blood flow is maintained through the inter-prong space of the clip, the OTSC is able to prevent tissue necrosis and aid wound healing. As necessary, the Twin Grasper (TG) forceps and Anchor (AC) forceps (Ovesco Endoscopy) are used as auxiliary forceps (Fig. 3) . The TG is a device that grasps both sides of a lesion through the separate and alternative opening of its blades. Conversely, the AC is a device in which three stretchable needles simultaneously grasp a lesion. Regarding these indications, the TG is applied to easily approximate the grasping edges of a large lesion, whereas the AC can better approximate indurated tissue. The clip lineup consists of three types of clips, namely, a gastrostomy closure type having a long and large prong indicated for the stomach; a traumatic type having short and sharp prongs, indicated for organs with thin walls, such as the small intestine and large intestine; and an atraumatic type indicated for hemorrhagic lesions. A treatment scope with a working channel of 3.2 mm or more diameter is recommended as a suitable endoscope. Double channel therapeutic scope (GIF-2T240, Olympus, Japan) with a large channel of 3.7-mm diameter may enable endoscopists to handle the TG or AC easily.
Procedure. The OTSC procedure intended for the complete closure of the entire defect is described as follows. (i) After the hand wheel is attached to the working channel, the applicator cap with a mounted clip is connected to the tip of the endoscope using a thread retriever. (ii) At the target site, the positioning for the OTSC placement is determined. (iii) If the entire defect can be sufficiently aspirated within the cap, simple aspiration is used; otherwise, the auxiliary forceps TG and AC forceps may be used according to the characteristics of the lesion. (iv) By turning the hand wheel quickly, similar to endoscopic variceal ligation, for one or more turns, the clip is deployed to the target and thereby completes the procedure. If a single clip is not enough to completely close the whole defect, an additional clip is to be added.
Overall clinical outcomes of the over-the-scope clip system
Clinical results, mainly from Europe, were sequentially reported between October 2010 and March 2018. Among them, PubMed searches including studies with 10 or more cases of describing experience with the OTSC system, using "Over-The-Scope Clip" and "endoscopic closure" as key terms, lead to 30 literature references. The clinical results are summarized in Table 1 . The summation of these 1517 cases showed that in the order of hemorrhage (n = 559), perforation (n = 351), fistula (n = 388), anastomotic dehiscence (n = 97), other conditions (n = 122), and overall (n = 1517), the clinical success rates (CSR) of the OTSC showed a mean of 84.6%, 84.6%, 51.5%, 66%, 95.1%, Figure 1 Components of over-the-scope clip (OTSC) system. The OTSC system is primarily composed of an OTSC mounted onto an application cap, a hand wheel, and a thread retriever. Figure 2 Simple mechanism of over-the-scope clip (OTSC) system. An OTSC mounted on the endoscope is fired by stretching the wire with the hand wheel, and the entire defect of the lesion is completely closed. and 78.3%, respectively. Clinical success was defined as the resolution of the troubled situation by the assessment of blood analysis, endoscopic, and/or radiographic imaging (surgery or further endoscopic intervention was not required during at least 1 month of follow-up after OTSC placement). Despite the somewhat poor performance of the OTSC system for fistula, the results were more than satisfactory when considering that there are no other effective methods currently available. With respect to safety, the OTSCrelated complication rate was 1.7% (26/1517 cases), of which the incidence rate of severe complications that required surgery was 0.59% (9/1517 cases), suggesting that the device is easy to use and relatively safe. Resection of submucosal tumor (n = 2) and stent fixation (n = 1). § § Endoscopic unroofing of a submucosal gastric tumor for biopsy (n = 2) and stent fixation (n = 1). ¶ ¶ Prophylaxis for perforations. a Prophylaxis for perforation 100% (24/24), diameter reduction of the gastrojejunal anastomosis 83.3% (5/6), and stent fixation 66% (2/3).
OTSC, over-the-scope clip.
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Clinical outcomes of the over-the-scope clip for different indications
Refractory bleeding. With regard to the current state of treatment for GI bleeding, the endoscopic hemostasis rate is reportedly between 90% and 95%, but there have also been cases with refractory bleeding. 40 Furthermore, the re-bleeding rate after endoscopic treatment is reportedly 10% to 20%, which is somewhat lacking in certainty. 40 Interventional radiology is attempted secondarily for cases that are resistant to endoscopic treatments, with surgery being selected as the last resort. However, the risk of emergency surgery itself is high in the elderly, with severe comorbidities, or for patients taking anticoagulant drugs. Therefore, there is a great deal of clinical significance in using OTSC as a new option before surgery. In recent years, many cases, approximately 100, have been accumulated demonstrating the usefulness of the OTSC system. 32, 35, 36 Richter-Schrag et al. 32 and Wedi et al. 37 have each reported good CSR results of 78% (78/100) and 92.4% (109/118), respectively. Conversely, these reports indicated that chronic fibrosis associated with protracted time as a cause of OTSC failure, meaning it is important not to extend beyond the intervention period. For this reason, Manno et al. 25 used OTSC as the first-choice treatment in 40 cases of fresh gastric ulcers for which conventional hemostatic methods are considered to involve a high risk of re-bleeding. The results showed no cases of re-bleeding and a high CSR of 100%. They reported that they were able to easily achieve hemostasis using the OTSC system for fresh and active ulcers, thereby emphasizing the excellence of introducing this approach as a first-line treatment for GI hemorrhage. Conversely, Lamberts et al. 35 reported that although immediate hemostasis (primary success rate) was achieved in 100% (75/75) of patients, re-bleeding occurred in up to 35% of those receiving antithrombotic/anticoagulant therapy, but these patients could be managed successfully with further endoscopic treatments. The authors concluded that the application of the OTSC system may be considered as a secondary option for high-risk patients when conventional therapies used as first-line treatment fail. In recent years, hemostatic methods using endoscopic hemostatic forceps, in addition to conventional hemoclips, have become more widespread. Therefore, when selecting a hemostatic method, intervention using the OTSC system may be a suitable option as a rescue treatment for cases that fail hemostasis with conventional methods and for cases of re-bleeding, even from the viewpoint of costeffectiveness. In contrast, OTSC plays an important role as firstline treatment for either upper or lower GI bleeding in high-risk patients. Summarizing the reports of different studies, we conclude that the mean CSR of the OTSC system for refractory bleeding was 84.6% (473/559 cases), which is an extremely high clinical effect among all the indicated diseases.
Perforation. The current status of GI perforation is such that perforation due to peptic ulcers is decreasing, thanks to treatment with proton pump inhibitors and eradication of Helicobacter pylori infections. Conversely, as advanced endoscopic techniques develop, the percentage of perforations accounted for by iatrogenic perforations is increasing. Therefore, in this review, we mainly discuss the current status of iatrogenic perforations and the relative performance of the OTSC system. Iatrogenic perforations reportedly occur in 0.01% to 0.6% of diagnostic endoscopy and in 0.6% to 5.5% of therapeutic endoscopy. 14, 40 As with bleeding, the conventional treatment for GI perforation is primarily surgery. However, emergency surgery in patients under poor general condition has not yielded good results, with a postoperative mortality rate exceeding 7% for GI perforations. 41, 42 Existing endoscopic treatments primarily involved hemoclips and stent placements. Although the success rate of hemoclip sutures for GI perforation has been reported to range between 69% and 100%, based on its characteristics, it is limited, as only lesions < 10 mm in size can be successfully sutured. 43 Although stents are used for esophageal perforations, various complications, including stent deviation, perforation, and mucosal damage during extubation, have been reported. 44, 45 For any of the existing treatments, it cannot be concluded that these are adequate methodologies, from the viewpoint of reliability and safety. Conversely, the OTSC system has shown clinical results over conventional methods. Heito-Chavez et al. 19 reported that the CSR for OTSC-treated cases, used primarily in 40 cases of iatrogenic perforations immediately after diagnosis, was 92% (37/40). They also added that 94% of cases with a relatively small mean size of perforation of 7 mm (range 4-11.5) achieved complete closure with a single use of OTSC. Voermans et al.
14 reported that the CSR of OTSC, used in 36 cases with relatively large perforations (approximately 3 cm), was 89% (32/36 cases), thereby demonstrating its usefulness. However, Hagel et al. 16 reported that the CSR of OTSC in 17 cases of perforation was slightly lower, at 64% (11/17 cases). For these, six cases, (i) necrosis and severe inflammation of the mucosa surrounding the perforation, (ii) mucosal ischemia, (iii) fibrosis of the perforated region, (iv) perforation of 20 mm or larger, (v) 72 or more hours elapsed since perforation, and (vi) upper to mid-esophageal perforation, were raised as possible causes of OTSC failure. Summarizing the reports of different authors, we may conclude that the mean CSR of OTSC used for treatment of perforation was 84.6% (297/ 351 cases), which is highly efficacious and very similar to that of refractory bleeding.
Gastrointestinal organs differ in anatomical characteristics, including total length, lumen width, and full-thickness layer width for each organ. Thus, the current status of OTSC system application for perforation will be outlined in detail below for each organ, adding anatomical and technical considerations.
Esophageal perforation. Voermans et al.
14 reported that OTSC was useful for cases of endoscopic mucosal resection (EMR)/postendoscopic submucosal dissection (ESD) perforation and esophageal perforations that occur during tracheal tube removal. Conversely, the attempts of Hagel et al. 16 to use OTSC in two cases of esophageal perforation ended without success. A potential explanation was that the defect could not be approximated using the TG forceps, because the EMR-associated perforation for Barrett's esophagus was in a tangential direction. Conversely, there has been a report of a successful closure of a large defect using the OTSC system by the TG assist for Boerhaave syndrome. 46 Because the esophagus is a tubular organ and the target can be tangential, there are limitations to the use of TG forceps required for the closure of large wounds. Nevertheless, the successful use of TG forceps requires advanced technical skills, such as wound shortening by air deaeration and maneuver of the endoscope, and this is likely to result in disparity in experience and technological application between physicians. However, considering the highly invasive nature of esophageal surgery, the OTSC approach is highly valued for its use for cases in which it is possible to grasp and close esophageal defects with good extensibility using a simple suction method, without being limited by TG forceps.
Gastric perforation. Iatrogenic perforation during endoscopic treatments involving percutaneous endoscopic gastrostomy and peptic ulcers-related perforations are the cases for which the OTSC system is primarily indicated. In cases of immediate-onset iatrogenic perforation, although OTSC provides a high success rate, OTSC approach is limited in cases with large ulcerous perforation of ≥ 4 cm and with tissue scarring. 14, 16 Conversely, the usefulness of the OTSC closure in a perforated site following gastric ESD has been reported. 47 In particular, the anatomical characteristic of the great curvature of the stomach, where the muscle layer is sparse, makes this section of the stomach prone to perforation. The OTSC system has reported to be effective for closure of delayed-onset perforation that occurs after ESD in the great curvature of the stomach, where the lumen is wide. 48 However, in the cardia and near the pyloric ring where the lumen is narrow, the OTSC needs to be used carefully considering post-placement luminal stenosis. For this reason, OTSC might prove to be an effective means of avoiding emergency surgery for procedural accidents associated with gastric ESD. 49 Small intestinal perforation. The duodenum, which the endoscope is able to reach, is a target region for the OTSC approach; thus, the clinical application of OTSC system for the deep small intestines remains controversial. The anatomical aspects of post-placement stenosis in the narrow lumen and the instrumental difficulties associated with no other reliable delivery methods may be suggested as potential reasons. Voermans et al.
14 reported a CSR of 75% (9/12 cases) for OTSC used in 12 cases of duodenal lesions. In our experience, the application of OTSC for iatrogenic duodenal perforation during endoscopic retrograde cholangiopancreatography helped avoid emergency surgery, demonstrating its outstanding efficacy (Fig. 4) . In addition, Buffoli et al. 50 reported that the OTSC was useful not only in the duodenum but also for a 2-cm jejunal perforation in the proximal small intestine that occurred during endoscopic retrograde cholangiopancreatography following a Billroth II procedure. To date, two ingenious approaches have been used to access the proximal small intestine: from the mouth or the anus. Fujihara et al. 51 have reported that the use of the colonoscope with waterjet function (PCF-Q260AI, Olympus, Tokyo, Japan) was effective for approaching a lesion in the third portion of the duodenum and for securing a field of vision. An alternative would be to consider the risk of intestinal laceration by the claws of OTSC and to deliver the OTSC safely to the terminal ileum by means of guidewire assist. 52 However, the methodology to deliver OTSC deeply into the small intestine have not yet been established and may be out of the therapeutic area of the OTSC system. Nevertheless, in the area of the small intestine, adaptive lesions should be carefully decided considering post-placement lumen stenosis.
Colonic perforation. While the rate of perforation associated with colonic EMR is low at 0.2%, the rate of perforation associated with ESD is relatively high, at 5%, due to the technical difficulty and the anatomical characteristics. 53 Haito-Chavez et al. 19 reported that the OTSC procedure was successful in all of 14 cases of iatrogenic perforation in the colon. Voermans et al.
14 also reported a good CSR of 92% (12/13 cases) for colonic perforations associated with polypectomy. Thus, while the application of OTSC for perforation associated with colonic ESD remains unclear, the OTSC approach is highly effective for instantaneous iatrogenic perforation. However, in cases of intraperitoneal contamination and peritonitis caused by leakage of intestinal fluid from the site of perforation, standard open surgery will be required.
Fistula. Histologically, fistula consists of chronic fibrotic tissue and has poor extensibility of the intestinal tract. According to the mechanism of the OTSC system, as with endoscopic variceal ligation, the successful key depends on the ability to suction the target lesion into the cap. 33 It is therefore reasonable that a mean CSR of 51.3% (200/388 cases) for fistulas makes it the least successful among all the indications of the OTSC system. HaitoChavez et al. 19 reported that there was a discrepancy between the technical success rate with 93% (85/91 cases) and CSR with 42.9% (39/91 cases) in a total of 91 cases of fistula after percutaneous endoscopic gastrostomy, following intestinal fistula tube removal, following bariatric surgery and malignant tumor-related fistula. Law et al. 23 also reported the same results, whereby despite a successful OTSC placement with a technical success rate of 87% (41/47 cases), 46% (19/41 cases) experienced a relapsed fistula after an average of 39 days. Based on these reports, it is possible to surmise that the main cause of delayed leakage was due to the inadequate grasping of indurated tissue of the fistula, in other words, the inability to grasp the entire layer. Conversely, focusing on the successful cases, the clinical success can be achieved only for relatively small fistula < 10 mm in size using a single OTSC. Therefore, as there currently is no available effective means of fistula closure other than surgery, OTSC can demonstrate a certain level of efficacy. In the future, it will be necessary to further consider indications by taking the fistula diameter into account.
Anastomotic dehiscence. The incidence rates of anastomotic dehiscence are reportedly from 0.4% to 5.2% after Rouxen-Y reconstruction, 54 1.6% to 13.6% after gastrectomy for malignant tumor, 55 and 3% to 33% after colon cancer surgery. 56 In principle, anastomotic dehiscence is circumvented by conservative treatments such as drainage and surgery in those who fail. Based on patient burden from re-surgery, it is one of the postoperative complications that also surgeons wish to avoid. HaitoChavez et al. 19 have reported the efficacy of the OTSC system for anastomotic dehiscence in a total of 30 cases with mean defect size of 8 mm (range 5-10 mm) following GI surgery, demonstrating a CSR of 73% (22/32 cases). As the main factors for success, application of OTSC within 1 week of diagnosis, low level of fibrosis, and lesions between 10 and 30 mm that are not very large can be proposed. 21 Conversely, Baron et al. 15 and Honegger et al. 34 reported that the success rate of OTSC for anastomotic dehiscence after esophageal surgery was below 33%, and the anatomical features of the esophagus, with the lumen being narrow, may influence this limited results. Summarizing previous reports, the mean CSR of OTSC closure for anastomotic dehiscence was moderate at 66% (64/97 cases). As with fistulas, the increased level of indurated tissue in proportion to the number of days elapsed after surgery likely affected the response rate of OTSC.
Others. Over-the-scope clip has a variety of other indications, including defect closures to prevent delayed perforation, 57 diagnosis, 20 and full-thickness resection 18 of the subepithelial lesion, stent fixation, 18, 20, 34 and preoperative marking. 11 Honegger et al. 34 reported the high efficacies of OTSC for the prophylaxis of perforation (100%, 24/24), diameter reduction of the gastrojejunal anastomosis (83.3%, 5/6), and stent fixation (66%, 2/3). In recent years, the high delayed perforation rate after duodenal ESD has been one of the challenges. 57 The use of OTSC for suturing of such large post-ESD wounds has been effective for preventing delayed complications, thereby making it possible to establish duodenal ESD. 39, 58 Summarizing different reports, the mean CSR of OTSC in these indications has been high at 95.1% (116/122 cases), and further indications for OTSC may be expected.
Over-the-scope clip system-associated complications
Based on aggregate results, the OTSC system can be considered a relatively safe device. All OTSC-related complications occurred in approximately 1.7% (26/1517) of cases, while severe complications occurred in 0.59% (9/1517 cases). Baron et al. 15 have reported two cases with jejunal stenosis after OTSC placement. Of these, one case underwent subsequent surgery after developing jejunal obstruction due to the extensive suturing of the lumen from multiple OTSC use. Furthermore, Mercky et al. 21 reported a total of four cases of procedural accidents, including OTSC deviation during the procedure, positional deviation due to tissue fibrosis, obstruction of the esophagogastric junction, and fistula injury due to the AC forceps. Other accidents include microperforation of a hemorrhagic duodenal ulcer due to the OTSC claws 12 and further maceration of the perforated site. 16, 33 Below, we summarize severe complications and provide countermeasures. As a countermeasure against intraluminal stenosis after placement of multiple clips, it is preferable to limit the sutures to half-circumference and to use up to two clips in the narrow lumen such as the gastroesophageal junction and small intestine. Where there is concern over stenosis, supplementing with several conventional hemoclips is recommended. Next, laceration wounds in the muscle layer and further maceration of the perforation may result from the claws of the released OTSC. For these countermeasures, it recommended to release the OTSC by suctioning the whole defect into the cap so that the clip does not tear the exposed muscle layer. A rare complication that small intestine was incorrectly grasped by OTSC during attempt to close an iatrogenic colonic perforation should be cautioned. 59 As a countermeasure, when closing a large perforation site, it is preferable to approximate the grasping edges of a large defect with the TG forceps to avoid the misdirected suctioning of neighboring organs. Accordingly, OTSC can become an even safer device by becoming familiar with the aforementioned points.
In unfortunate situations where the OTSC is placed inappropriately or the placement causes stenosis of the GI tract, one might be forced to recover it. For better utilized, endoscopic dye staining (tattooing) in the target lesion by injecting India ink can be an effective method for assisting the accurate placement of the clip. 31 During recovery, the use of argon plasma coagulation 11 and a hydrophilic guidewire 60 was reported to be effective for removal of the placed OTSC. However, recovery method might be neither easy nor useful. Currently, Schmidt et al. 61 have reported on the usefulness of a novel cutting device (DC ClipCutter; Ovesco Endoscopy), and its clinical introduction is expected.
Summary and conclusion
This review is the first report to summarize the performance the OTSC system for each of its recommended indications, namely, refractory bleeding, perforation, fistula, and anastomotic dehiscence. The characteristic of this review is that it summarized 1517 cases, accumulated over 9 years between 2010 and 2018, where the OTSC system was clinically applied in reports describing over 10 cases.
Less invasive endoscopic therapy are preferred for these indications, when taking into consideration the unstable general condition of patients during emergency surgery. Today, refractory bleeding accompanied by an increase in antithrombotic drug use and the management of complications accompanying advanced endoscopic procedures, such as ESD and interventional endoscopic ultrasonography, are being closely monitored. 57, 62 This OTSC system is well suited to the current trends and has spread worldwide, mainly from Europe and the USA to Asian territories and India, 31 and its usefulness has become well defined. This review indicates a high success rate of OTSC to refractory bleeding, with a mean CSR of 84.6%. However, the indication for OTSC in GI bleeding will be limited in the present situation where various hemostatic methods have been established. Whereas one of the great advantages of OTSC is that antiplatelet medicines can be used soon after placement of clip especially in patients with newly placed coronary stents, while it is not possible for any other modalities due to the risk of re-bleeding. Consequently, we emphasize that OTSC is a suitable option as first-line treatment for either upper or lower GI bleeding in high-risk patients who have severe comorbidities or take anticoagulant drugs. OTSC can also provide a high success rate for perforation similar to refractory bleeding. The successful key of OTSC is whether or not the target tissue can be suctioned into the cap. 33 Therefore, immediate iatrogenic perforation and acute-onset perforation often have relatively soft target tissues, leading to the success of OTSC procedure. With regard to the size of successful OTSC closure for acute-onset defects, the upper limit of defect size is set to 30 mm, and a diameter up to 15 mm can be completely closed with a single OTSC clip. 10 Meanwhile, the mean CSR of OTSC was lowest for fistula, at 51% among the all indications. Even if the technical success is completed, delayed leakage tends to occur often. This main reason is presumed to be the inadequate grasping of the tissue due to severe fibrosis, and to be the possibility that the full thickness cannot be grasped, so there is a limitation to its mechanism. Regarding the size of the fistula closure, most reports of successful cases have targeted fistula sizes of 10 mm or less, and it is desirable to set 10 mm as the cut-off value. However, in view of the present circumstances where there are no effective means existing for treating fistula, OTSC can be a groundbreaking device with satisfactory result.
The mean CSR of OTSC for anastomotic dehiscence is moderate, at 66%. While inadequate at CSR of 33.3% (6/18) according to the report of Honegger et al., 34 Raithel et al. 30 and Lee et al. 38 have both reported good results with a CSR at 83.3% (10/12). This discrepancy is related to the timing of OTSC introduction. The increase in tissue hardening at the site of anastomotic dehiscence with the number of days elapsed after surgery is thought to have an effect on the response rate. Therefore, OTSC application would be most effective at the onset of anastomotic dehiscence to avoid more invasive additional surgeries.
In the future, the closure of hardened tissue at the site of large fistulas and anastomotic dehiscence, which are the limitations of the OTSC system, may be overcome using newer full-thickness suturing devices. 63, 64 This study concludes that, despite remaining issues with fistulas, the OTSC system is a safe and useful device for refractory GI diseases. The present review, which summarized its performance for each indication and related complications, indicated that the OTSC system could provide maximum benefits for rescue therapies. The OTSC system can be considered an innovative device, which extends into a novel field of full-thickness suturing that is beyond the conventional framework of endoscopic treatments.
